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Centers for Population Health and Health
Disparities
The purpose of the Centers for Population Health
and Health Disparities (CPHHD) is to support
interdisciplinary research leading to an understand-
ing and reduction of health disparities in domestic
populations. Applicants are invited to propose mul-
tilevel, integrated research projects that will elucidate
the complex interactions of the social and physical
environment, mediating behavioral factors, and bio-
logic pathways that determine health and disease.
The CPHHD is expected to create an environment
conducive to interdisciplinary and reciprocally bene-
ficial collaborations among biomedical scientists,
social scientists, and affected communities, with the
common goal of improving population health and
reducing health disparities.
This is a trans-NIH request for applications
(RFA) sponsored jointly by the NIEHS, the
National Cancer Institute (NCI), the National
Institute on Aging (NIA), and the Office of
Behavioral and Social Science Research. Applicants
are encouraged to propose research across disease
outcomes or health-related issues relevant for these
institutes.
To achieve this goal, the CPHHD will sup-
port three or more thematically linked research
projects, facility cores that support two or more
projects, an administrative core, and pilot projects.
The CPHHD will present opportunities to con-
currently study biological, behavioral, psychologi-
cal, cultural, and social precursors of disease.
A key objective is to generate a research pro-
gram that embraces the concept of multiple levels
of analysis in health sciences to examine factors
operating at the social/environmental,
behavioral/psychological, and biological (organ sys-
tem, cellular, and molecular) levels. Centers should
propose mechanistic and intervention studies
across multiple levels of analysis and across diseases
and conditions relevant to the mission of the spon-
soring institutes.
The theme of a proposed CPHHD research
project may be organized to examine a) a single
condition for which a significant disparity in mor-
bidity and/or mortality between populations has
been demonstrated (e.g., obesity, infant mortality,
low birth weight, diabetes, CHD, asthma, cancer),
its relationship to multiple social and physical envi-
ronmental determinants, and their mechanistic
pathways; or b) a particular category of social envi-
ronmental determinant (e.g., food supply, urban
crowding, built environment, social support) and
mechanistic pathways by which it affects multiple
health outcomes for which disparities have been
demonstrated between populations.
This RFA supports research across multiple
levels of analysis. Applicants must develop a the-
matic focus that can be carried across
population(s), behavior, and biologic pathways for
the diseases or conditions under study. At least two
of the following levels must be addressed in pro-
posed research projects.
Social/Environmental Level
More needs to be learned about the effects of social
networks, social capital, racism, and other forms of
social injustice at the population level on risk fac-
tor behaviors, disease incidence, and stage of dis-
ease at diagnosis. This includes the influence of
social policies, the impact of social hierarchies, and
factors related to control in the workplace.
Population health models are needed for investiga-
tions that include the community as a unit of
analysis; measurements of cumulative social, physi-
cal, and behavioral antecedents or exposures; the
characteristics of “healthy communities” and
health-promoting environments; characteristics of
“toxic” community environments and interven-
tions to remedy these conditions; protective factors
and mechanisms promoting positive health out-
comes and disease prevention; human resilience,
resistance to disease, and factors supporting posi-
tive health behaviors.
Examples of activities relevant to the sponsor-
ing institutes include but are not limited to:
1)  examining differential social gradients for
specific cancer sites and the contribution of
known risk factors to these gradients;
2)  identifying and elucidating pathways by
which the built environment exerts influence
on persons with functional disabilities and on
diverse health outcomes such as infant mor-
bidity and mortality, asthma, perturbations
of the immune system, degenerative or devel-
opmental neurologic disorders, cognitive dis-
orders, behavioral disorders, sensory impair-
ment, and cardiovascular disease;
3)  elucidating the role of the social and physical
environments and behavioral and biologic
pathways in explaining the persistent dispari-
ties in cervical cancer mortality;
4)  evaluating whether social class or other social
factors affect the availability and efficacy of
therapeutic interventions for diseases such as
sickle cell disease that predominately affect
specific population subgroups;
5)  increasing emphasis on the collection of bio-
markers in epidemiologic studies of social
relationships and health;
6)  examining the consequences of retirement on
health and functioning;
7)  characterizing differentials in income and
wealth accumulation for subpopulations
(such as elderly, racial and ethnic minorities,
preretirement workers) and identifying the
sources of these differentials and their
impacts on health status.
Behavioral/Psychological Level
Individual risk behaviors (including poor diet, lack
of exercise, smoking, alcohol abuse, saving and
nonsaving behaviors among the elderly) may be
critical factors in the etiology and progression of
chronic diseases. However, for purposes of this
RFA and to advance our understanding of popula-
tion health, applicants should focus on the factors
that affect health disparities among population
subgroups, rather than solely on high-risk individ-
uals. The effectiveness of many interventions is
related to social factors that determine group
behaviors, such as affordability of drugs/foods,
communication, trust, and cultural beliefs.
Examples of relevant activities that involve this
level of analysis include 1) elucidation of the path-
ways invoked by protective factors and mecha-
nisms that act at a population level to result in pos-
itive health behavior and outcomes, and 2) the
extent to which the population prevalence of
known risk factors such as tobacco use, altered cog-
nitive function, suboptimal diet, low physical
activity, personality, and inadequate screening
practices explain observed social gradients in dis-
ease incidence, morbidity, and mortality and dis-
ability.
Biological Levels
The biologic pathways through which social deter-
minants might affect disease incidence, severity,
and outcomes may be studied in diseases for which
a significant disparity exists. Applicants are encour-
aged to propose studies that examine genetic sus-
ceptibility in relation to social characteristics and
exposures and the connection to positive and nega-
tive health outcomes, and the relationship between
social conditions and phenotype.
Examples of activities of relevance to the spon-
soring institutes include but are not limited to:
1) employing animal models, including applica-
tion of methods to examine gene mutations
and gene expression in relation to social
and/or physical environmental exposures;
2) identifying and characterizing the social and
environmental factors that interact with
genetic susceptibility to disease and patho-
physiologic factors to contribute to variation
in the prevalence of cancer, cardiopulmonary
conditions, and other chronic diseases;
3) exploring the biologic pathways by which
various exposures (e.g., polychlorinated
biphenyls, mercury, lead) and social and cul-
tural conditions influence neurodevelopmen-
tal and cognitive outcomes;
4) evaluating genetic factors or pathophysiologic
mechanisms by which social and physical
environments contribute to disparities in the
prevalence of asthma, CHD, and diabetes in
population subgroups;
5) determining whether social factors are equally
involved in differential cancer prevalence in
various subgroups, and elucidating the impli-
cations to disparities in health;
6) evaluating the interaction between social, cul-
tural, educational, or lifestyle factors and
genetic variability on cognitive decline and
dementia in older population subgroups;
7) exploring the role of social/environmental
factors in explaining observed biologic vari-
ability in response to heart failure, cancer,
asthma, or other therapies.
Methodologic Research
Integration of multiple levels of analysis, as
described above, may warrant the refinement of
existing methodologic approaches or the develop-
ment of novel methodologic approaches in the
conduct of CPHHD research projects.
Methodologic research is supported by this RFA to
the extent that it is requisite to the achievement of
specific aims outlined in CPHHD applications.
Research at various levels of analysis could be
facilitated by methodologic advances in such areas as:
1)  development of methods to improve the assess-
ment of physical, social, psychological, behav-
ioral, and cultural environmental exposures;
2) development of innovative and effective ways
to integrate qualitative and quantitative
research methods needed to investigate the
complex, multilayered nature of psychoso-
cial, behavioral, and cultural influences on
health and functioning;
3) development of statistical methods to delin-
eate relationships among behavioral, psy-
chosocial, environmental, and biologic levels
of analysis;
4) development of the most useful contextual
measures of socioeconomic status (SES) at
the level of neighborhoods or census tracts,
how these measures relate to individual SES,
and how this relationship varies for different
disease outcomes;
5) development of design, implementation, and
analysis strategies for multicomponent inter-
ventions that include adaptive tuning of duration
or intensity to achieve optimal effects;
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6) development of standardized approaches to
assessing the collective health of communities.
Support of this program will be through the
P50 Specialized Centers Grant. The anticipated
award date is 1 April 2003.
The sponsoring institutes intend to commit
approximately $15 million (NIEHS $5 million,
NCI $8 million, and NIA $2 million) in fiscal year
2003 to fund seven or eight new grants in response
to this RFA. An applicant may request a project
period of up to 5 years and a budget for direct
costs of up to $1.3 million per year.
The deadline for receipt of applications is 29
July 2002. Complete information on this
announcement is available online at
http://grants1.nih.gov/grants/guide/rfa-files/RFA-
ES-02-009.html.
Contact: Suzanne Heurtin-Roberts, NCI,
Division of Cancer Control and Population
Sciences, 6130 Executive Blvd., EPN 4054,
Bethesda, MD 20892 USA, 301-594-6655, fax:
301-435-7547, e-mail: sheurtin@mail.nih.gov;
Frederick L. Tyson, Chemical Exposures and
Molecular Biology Branch, NIEHS, P.O. Box
12233, 111 T.W. Alexander Drive (EC-21),
Research Triangle Park, NC 27709 USA, 919-
541-0176, fax: 919-316-4606, e-mail:
tyson2@niehs.nih.gov;
Georgeanne E. Patmios, NIA, Behavioral and
Social Research Program, 7201 Wisconsin Avenue,
Gateway Building, Suite 533, Bethesda, MD
20892-7936 USA, 301-496-3138, fax: 301-402-
0051, e-mail: patmios@nih.gov. 
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